Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 27Other hematologic neoplasm 21Breast 13Plasma cell 4Sarcoma 2Myeloid 2Other 1Genitourinary 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Obesity 1Breast Neoplasms 1Body Weight 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Lidocaine 2Injections 2Docosahexaenoic Acids 2Diet 2sibutramine 1polyethylene glycol 3350 1oxycodone-acetaminophen 1naloxegol 1naldemedine 1methylnaltrexone 1Ursodeoxycholic Acid 1Tramadol 1Topiramate 1Solutions 1Sennosides 1Resistance Training 1Quality of Life 1Propofol 1Progestins 1Polyethylene Glycols 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cyclophosphamide × Other × Clear all
NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡